But most other researches indicated that hyperprolactinemia was found to be associated with SLE disease activity and conventional immunosuppressive therapy decreased PRL levels as well as SLE activity [18], and elevated serum bioactive prolactin concentrations in SLE patients were associated with disease activity [19]. Here, PRL is linked to systemic lupus erythematosus.